David Hoang

Stock Analyst at Deutsche Bank

(0)
# 4570
Out of 5,358 analysts
44
Total ratings
42.31%
Success rate
-13.61%
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
ACAD ACADIA Pharmaceutica...
Upgrades: Buy
20 35
21.97 59.31% 5 May 21, 2025
ALKS Alkermes
Maintains: Strong Buy
40 52
31.72 63.93% 2 Mar 27, 2025
SRPT Sarepta Therapeutics
Maintains: Hold
124 99
43.02 130.13% 6 Mar 19, 2025
XENE Xenon Pharmaceutical...
Initiates Coverage On: Buy
67
31.64 111.76% 3 Feb 11, 2025
PRAX Praxis Precision Med...
Initiates Coverage On: Buy
111
44.52 149.33% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
55
35.58 54.58% 2 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
31
14.7 110.88% 3 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
65
17.01 282.13% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
176
111.92 57.26% 4 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
9.74 23.2% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
150 158
125.42 25.98% 4 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
45 50
n/a n/a 3 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
1.21 478.51% 1 Jul 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
8
6.84 16.96% 1 May 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
4.54 252.42% 1 Mar 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
3.53 353.26% 1 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
220
300.77 -26.85% 1 Apr 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
80
16.8 376.19% 1 Apr 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
15 25
n/a n/a 1 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3
1.32 127.27% 1 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Apr 1, 2022